South America Latent TB Detection Market

Historic Data: 2018-2019   |   Base Year: 2020   |   Forecast Period: 2021-2027

Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)) and End User (Hospitals, Diagnostic Centers, Laboratories, and Others)

No. of Pages: 107
Report Code: TIPRE00024702
Category: Life Sciences
South America Latent TB Detection Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South America Latent TB Detection Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South America Latent TB Detection Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South America Latent TB Detection Market Regional Analysis

6.2 South America Latent TB Detection Market Revenue 2018-2027 (US$ Million)
6.3 South America Latent TB Detection Market Forecast Analysis

7. South America Latent TB Detection Market Analysis – by Test

7.1 Tuberculin Skin Test
  • 7.1.1 Overview
  • 7.1.2 Tuberculin Skin Test: South America Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
7.2 Interferon Gamma Released Assay
  • 7.2.1 Overview
  • 7.2.2 Interferon Gamma Released Assay: South America Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)

8. South America Latent TB Detection Market Analysis – by End User

8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Hospitals: South America Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
8.2 Diagnostic Centers
  • 8.2.1 Overview
  • 8.2.2 Diagnostic Centers: South America Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
8.3 Laboratories
  • 8.3.1 Overview
  • 8.3.2 Laboratories: South America Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)

9. South America Latent TB Detection Market – South and Central America Analysis

9.1 Overview

9.2 South and Central America
  • 9.2.1 South America Latent TB Detection Market Breakdown, by Key Country, 2021 and 2027 (%)
  • 9.2.1.1 South America Latent TB Detection Market – Revenue and Forecast Analysis – by Country
  • 9.2.1.1 Brazil: South America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.1.1 Brazil: South America Latent TB Detection Market Breakdown, by Test
    • 9.2.1.1.2 Brazil: South America Latent TB Detection Market Breakdown, by End User
  • 9.2.1.2 Argentina: South America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.2.1 Argentina: South America Latent TB Detection Market Breakdown, by Test
    • 9.2.1.2.2 Argentina: South America Latent TB Detection Market Breakdown, by End User
  • 9.2.1.3 Rest of South and Central America : South America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.3.1 Rest of South and Central America : South America Latent TB Detection Market Breakdown, by Test
    • 9.2.1.3.2 Rest of South and Central America : South America Latent TB Detection Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments

12. Company Profiles

12.1 Abbott
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 ARKRAY, Inc.
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 BD
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 bioMerieux SA
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 F. HOFFMANN-LA ROCHE LTD.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Oxford Immunotec Ltd
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 QIAGEN
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Serum Institute of India Pvt. Ltd.
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights
13.2 List of Abbreviations

The List of Companies - South America Latent TB Detection Market

  • Abbott
  • ARKRAY, Inc.
  • BD
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • Oxford Immunotec Ltd
  • QIAGEN
  • Serum Institute of India Pvt. Ltd.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)